Effects of MiR-135a-5p and MiR-141 on Proliferation, Invasion and Apoptosis of Colorectal Cancer SW620 Cells

Overview

Journal Oncol Lett

Specialty Oncology

Date 2020 Jun 23

PMID 32566020

Citations 8

Authors

Jian Wang

Jing Yang

Heng Zhang

Yusheng Liao

Dan Xu

Songlin Ma

Affiliations

Soon will be listed here.

Abstract

Effects of miR-135a-5p and miR-141 on the biological function of colorectal cancer SW620 cells were investigated. Fifty-four specimens of cancer tissues and 54 specimens of corresponding adjacent tissues in colon cancer patients who were treated in The Central Hospital of Wuhan from March 2014 to March 2015 were collected. RT-PCR was used to detect the expression levels of miR-135a-5p and miR-141 in cancer tissues and adjacent tissues. The miR-135a-5p inhibitor and miR-141 mimic carriers were established. The cell proliferation was detected by CCK8, the invasion ability of cells was evaluated by Transwell chamber, and cell apoptosis of each group was detected by flow cytometry. The results of RT-qPCR showed that expression levels of miR-135a-5p in colorectal cancer tissues were significantly higher than those in adjacent tissues, the expression levels of miR-141 in colorectal cancer tissues were significantly lower than those in adjacent tissues, and the difference was statistically significant (P<0.001). The cell survival rates of the miR-135a-5p inhibitor group and the miR-141 mimic group were significantly lower than those of the NC group and the blank group 48 and 72 h after transfection (P<0.001). The number of invasive cells in the miR-135a-5p inhibitor group and the miR-141 mimic group was significantly lower than that in the blank group and the NC group (P<0.001). Apoptosis rate was significantly higher than that of the NC group and the blank group (P<0.001). In conclusion, low expression levels of miR-135a-5p and miR-141 in colorectal adenomas suggested that miR-135a-5p and miR-141 could act as tumor suppressors in the development of colorectal adenomas; miR-135a-5p and miR-141 inhibited the proliferation and invasion of colon cancer SW620 cells and promoted apoptosis of colon cancer cells.

Citing Articles

Circulating cell-free and extracellular vesicles-derived microRNA as prognostic biomarkers in patients with early-stage NSCLC: results from RESTING study.

Petracci E, Pasini L, Urbini M, Felip E, Stella F, Davoli F J Exp Clin Cancer Res. 2024; 43(1):241.

PMID: 39169404 PMC: 11340091. DOI: 10.1186/s13046-024-03156-y.

Role of non-coding RNAs as new therapeutic targets in regulating the EMT and apoptosis in metastatic gastric and colorectal cancers.

Ebrahimi N, Hakimzadeh A, Bozorgmand F, Speed S, Manavi M, Khorram R Cell Cycle. 2023; 22(20):2302-2323.

PMID: 38009668 PMC: 10730205. DOI: 10.1080/15384101.2023.2286804.

MiR-135a-5p suppresses breast cancer cell proliferation, migration, and invasion by regulating BAG3.

Zhang H, Wang M, Lang Z, Liu H, Liu J, Ma L Clinics (Sao Paulo). 2022; 77:100115.

PMID: 36228497 PMC: 9573871. DOI: 10.1016/j.clinsp.2022.100115.

The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.

Ferris W Front Oncol. 2022; 12:903374.

PMID: 35847932 PMC: 9277020. DOI: 10.3389/fonc.2022.903374.

Regulation of Gamma-Aminobutyric Acid Transaminase Expression and Its Clinical Significance in Hepatocellular Carcinoma.

Gao X, Jia X, Xu M, Xiang J, Lei J, Li Y Front Oncol. 2022; 12:879810.

PMID: 35847853 PMC: 9280914. DOI: 10.3389/fonc.2022.879810.

References

Tauriello D, Batlle E . Targeting the Microenvironment in Advanced Colorectal Cancer. Trends Cancer. 2017; 2(9):495-504. DOI: 10.1016/j.trecan.2016.08.001. View

Zheng Y, Li S, Boohaker R, Liu X, Zhu Y, Zhai L . A MicroRNA Expression Signature In Taxane-anthracycline-Based Neoadjuvant Chemotherapy Response. J Cancer. 2015; 6(7):671-7. PMC: 4466417. DOI: 10.7150/jca.11616. View

Guinney J, Dienstmann R, Wang X, De Reynies A, Schlicker A, Soneson C . The consensus molecular subtypes of colorectal cancer. Nat Med. 2015; 21(11):1350-6. PMC: 4636487. DOI: 10.1038/nm.3967. View

Mansoori B, Mohammadi A, Ghasabi M, Shirjang S, Dehghan R, Montazeri V . miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. J Cell Physiol. 2018; 234(6):9816-9825. DOI: 10.1002/jcp.27670. View

Tsukamoto M, Iinuma H, Yagi T, Matsuda K, Hashiguchi Y . Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Oncology. 2017; 92(6):360-370. DOI: 10.1159/000463387. View

Pietrantonio F, Petrelli F, Coinu A, Di Bartolomeo M, Borgonovo K, Maggi C . Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis. Eur J Cancer. 2015; 51(5):587-94. DOI: 10.1016/j.ejca.2015.01.054. View

Hu J, He G, Lan X, Zeng Z, Guan J, Ding Y . Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer. Oncogenesis. 2018; 7(2):16. PMC: 5833763. DOI: 10.1038/s41389-018-0028-8. View

Casasent A, Schalck A, Gao R, Sei E, Long A, Pangburn W . Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing. Cell. 2018; 172(1-2):205-217.e12. PMC: 5766405. DOI: 10.1016/j.cell.2017.12.007. View

Shenas M, Eghbal-Fard S, Mehrisofiani V, Abd Yazdani N, Farzam O, Marofi F . MicroRNAs and signaling networks involved in epithelial-mesenchymal transition. J Cell Physiol. 2018; 234(5):5775-5785. DOI: 10.1002/jcp.27489. View

10.

Fang F, Chang R, Yu L, Lei X, Xiao S, Yang H . MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. J Hepatol. 2015; 63(4):874-85. DOI: 10.1016/j.jhep.2015.05.008. View

11.

Lima C, Geraldo M, Fuziwara C, Kimura E, Santos M . MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells. BMC Cancer. 2016; 16:108. PMC: 4754828. DOI: 10.1186/s12885-016-2146-z. View

12.

Ling H, Pickard K, Ivan C, Isella C, Ikuo M, Mitter R . The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut. 2015; 65(6):977-989. PMC: 4581915. DOI: 10.1136/gutjnl-2015-309372. View

13.

Penna E, Orso F, Taverna D . miR-214 as a key hub that controls cancer networks: small player, multiple functions. J Invest Dermatol. 2014; 135(4):960-969. DOI: 10.1038/jid.2014.479. View

14.

Zhu X, Han S, Wu S, Bai Y, Zhang N, Wei L . Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer. Exp Cell Res. 2019; 375(2):41-50. DOI: 10.1016/j.yexcr.2019.01.002. View

15.

Dong H, Weng C, Bai R, Sheng J, Gao X, Li L . The regulatory network of miR-141 in the inhibition of angiogenesis. Angiogenesis. 2018; 22(2):251-262. DOI: 10.1007/s10456-018-9654-1. View

16.

Fernandez S, Risolino M, Mandia N, Talotta F, Soini Y, Incoronato M . miR-340 inhibits tumor cell proliferation and induces apoptosis by targeting multiple negative regulators of p27 in non-small cell lung cancer. Oncogene. 2014; 34(25):3240-50. PMC: 4724947. DOI: 10.1038/onc.2014.267. View

17.

Liao J, Liu R, Shi Y, Yin L, Pu Y . Exosome-shuttling microRNA-21 promotes cell migration and invasion-targeting PDCD4 in esophageal cancer. Int J Oncol. 2016; 48(6):2567-79. DOI: 10.3892/ijo.2016.3453. View

18.

Moriarity A, OSullivan J, Kennedy J, Mehigan B, McCormick P . Current targeted therapies in the treatment of advanced colorectal cancer: a review. Ther Adv Med Oncol. 2016; 8(4):276-93. PMC: 4952023. DOI: 10.1177/1758834016646734. View

19.

Siegel R, Miller K, Fedewa S, Ahnen D, Meester R, Barzi A . Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017; 67(3):177-193. DOI: 10.3322/caac.21395. View

20.

Tang W, Wan S, Yang Z, Teschendorff A, Zou Q . Tumor origin detection with tissue-specific miRNA and DNA methylation markers. Bioinformatics. 2017; 34(3):398-406. DOI: 10.1093/bioinformatics/btx622. View